Skip to main content
2025 CRT Conference Main banner

CRT 2025

Technology and Innovation

Renal Denervation and Hypertension Therapies

Redesigning Hypertension Clinical Trials for Devices and Drugs

Sunday, March 9, 2025
10:52 AM - 11:00 AM ET

    Speaker(s)

  • Michael J. Bloch, MD

    Medical Director, Vascular Care
    Renown Institute for Heart and Vascular Health
    reno, Nevada, United States

    No relationships to disclose

Disclosure(s):
Michael J. Bloch, MD: Amgen: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); baralogics: Consulting Fees (e.g., advisory boards) (Ongoing); corcept: Consulting Fees (e.g., advisory boards) (Ongoing); esperion: Consulting Fees (e.g., advisory boards) (Ongoing); idorsia pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); janssen: Consulting Fees (e.g., advisory boards) (Ongoing); medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Novartis Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); Recor Medical, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); SoniVie: Grant/Research Support (Ongoing)